关注
Philip Salu
标题
引用次数
引用次数
年份
Advancements in circulating tumor cell research: bridging biology and clinical applications
P Salu, KM Reindl
Cancers 16 (6), 1213, 2024
22024
Advancements in Preclinical Models of Pancreatic Cancer
P Salu, KM Reindl
Pancreas 53 (2), e205-e220, 2024
22024
Nanocarrier mediated entinostat and oxaliplatin combination therapy displayed enhanced efficacy against pancreatic cancer
PM Giri, A Kumar, P Salu, V Sathish, K Reindl, S Mallik, B Layek
Biomedicine & Pharmacotherapy 175, 116743, 2024
2024
Abstract LB192: AGR2 knockdown reduces cell proliferation and increases endoplasmic reticulum proteotoxic stress in pancreatic cancer
P Salu, K Reindl
Cancer Research 84 (7_Supplement), LB192-LB192, 2024
2024
系统目前无法执行此操作，请稍后再试。
文章 1–4